Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: Teladoc vs. Amwell

TheMotleyFool

0 0

In this video I will be going over Teladoc's (NYSE: TDOC) recent earnings and comparing it to one of its competitors, Amwell (NYSE: AMWL). While one's business has been improving, the other's has been declining. You can find the full video below.

Teladoc Health's organic revenue grew by 41% vs. 69% sequentially. The company reported total revenue of $503 million, up 108.7% year over year and 10.8% quarter over quarter.

The company expects Q3 revenue to come in between $510 million and $520 million, a 78% YOY growth at the midpoint, and total visits to be between 3.4 million and 3.6 million, a 23.5% YOY growth at the midpoint.

Source Fool.com

Like: 0

TDOC

Share